Riskpilot← Back to searchSign inGet full accessOAC MEDICAL AS
ASActiveOrg 927423715Ruseløkkveien 34, 0251 OsloDevelopment of building projects · NACE 6812Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
+21% vs 2023
Equity ratio
91.8%
Financial strength
Net profit 2024
NOK -1,6M
-517% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -59K | +21% |
| Net profit | NOK -1,6M | -517% |
| Total assets | NOK 1,1M | -56% |
| Equity | NOK 969K | +336% |
| Employees | 0 | — |
Legal name
OAC MEDICAL AS
Org number
927423715
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
15. juli 2021
Share capital
NOK 40 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Utvikling, salg og utleie av fast eiendom knyttet til legemiddelindustri og annet som naturlig faller sammen med dette.
Address
Ruseløkkveien 34, 0251 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −18 | −83 | −74 | −59 |
| Depreciation & amort. | −0 | −0 | −0 | −1 359 |
| EBIT | −18 | −83 | −74 | −1 418 |
| Net financials | −9 | −63 | −188 | −202 |
| Profit before tax | −27 | −145 | −262 | −1 620 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −27 | −145 | −262 | −1 620 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 365 | 2 397 | 2 420 | 1 057 |
| Equity | −3 | −148 | −410 | 969 |
| Long-term debt | 828 | 2 542 | 2 824 | 57 |
| Short-term debt | 539 | 3 | 7 | 30 |
| Total debt | 1 367 | 2 545 | 2 831 | 87 |
EBITDA margin
-5850800.0%
This company
15.8%
Market median
-37030480% vs market
20212024
Equity ratio
91.8%
This company
38.2%
Market median
+140% vs market
20212024
Return on equity
-167.1%
This company
18.4%
Market median
-1008% vs market
20212024
Net profit margin
-162008000.0%
This company
8.1%
Market median
-2000098865% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Chairman | 2022 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Brødrene Jensen Holding Ii As
OAC MEDICAL AS Board members of OAC MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thor Egil Thoeneie | Chairman | 0 companies |
| Henrik Marius Sterling Danielsen | Chairman | 0 companies |
| Elianne Beate Meland | Board of Directors | 0 companies |
| Anders Vedal | Board of Directors | 0 companies |
| Fredrik Rustan Torgersen | Chairman | 0 companies |